Long-Term Efficacy and Safety of Empagliflozin Monotherapy in Drug-Naïve Patients with Type 2 Diabetes in Indian Subgroup: Results from a 76-week Extension Trial of Phase III, Double-Blind, Randomized Study
2017 ◽
Vol 21
(2)
◽
pp. 286
◽
Viraj Suvarna
◽
Sunil Gupta
◽
Shehla Shaikh
◽
Pooja Joshi
◽
Shraddha Bhure
2012 ◽
Vol 36
(2)
◽
pp. 237-244
◽
J. B. McGill
◽
L. Sloan
◽
J. Newman
◽
S. Patel
◽
C. Sauce
◽
...
Pierre Ronco
◽
Jean-Jacques Boffa
M Roden
◽
L Merker
◽
F Roux
◽
A Salsali
◽
G Kim
◽
...
2018 ◽
Vol 67
(Supplement 1)
◽
pp. 1129-P
SILVINA GALLO
◽
BERNARD CHARBONNEL
◽
ALLISON GOLDMAN
◽
HARRY SHI
◽
SUSAN HUYCK
◽
...
2017 ◽
Vol 96
(27)
◽
pp. e7201
◽
Jian Li
◽
Yanping Gong
◽
Chunlin Li
◽
Yanhui Lu
◽
Yu Liu
◽
...
2011 ◽
Vol 35
(2)
◽
pp. 252-258
◽
D. Russell-Jones
◽
R. M. Cuddihy
◽
M. Hanefeld
◽
A. Kumar
◽
J. G. Gonzalez
◽
...
2017 ◽
Vol 123
◽
pp. 9-17
◽
Ippei Kanazawa
◽
Ken-ichiro Tanaka
◽
Masakazu Notsu
◽
Sayuri Tanaka
◽
Nobuaki Kiyohara
◽
...
2016 ◽
Vol 18
(5)
◽
pp. 528-532
◽
S. Hong
◽
C.-Y. Park
◽
K. A. Han
◽
C. H. Chung
◽
B. J. Ku
◽
...
2004 ◽
Vol 15
(8)
◽
pp. 496-502
◽
Bernhard O. Boehm
◽
Julius A. Vaz
◽
Lise Brøndsted
◽
Philip D. Home
2016 ◽
Vol 55
(10)
◽
pp. 1275-1278
◽
Yuko Tada
◽
Ippei Kanazawa
◽
Masakazu Notsu
◽
Ken-ichiro Tanaka
◽
Nobuaki Kiyohara
◽
...
Close
Export Citation Format
Close
Share Document
Close